Researchers discover cause of a new rare genetic condition: Glutamine synthetase stabilization disorder

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

An international team of researchers has discovered what causes an unusual and incredibly rare genetic condition, giving hope to the families with it and others with related disorders.

Researchers discover cause of a new rare genetic condition: Glutamine synthetase stabilization disorder retrieved 15 April 2024 from https://medicalxpress.com/news/2024-04-rare-genetic-condition-glutamine-synthetase.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.2 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Medicine Research Health Research News Health Research Health Science Medicine Science

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers find new genetic cause of severe combined immune deficiency diseaseResearchers from Nijmegen and Newcastle have discovered a new genetic mutation leading to severe combined immune deficiency disorder (SCID). It's the first time a mutation in the proteasome, a molecular shredder, has been linked to this serious disease.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers study newborn piglets to better understand the progression of influenzaAlthough prevention and treatment strategies are available for influenza, they are not sufficient for vulnerable populations such as young children and newborns.
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers create a method to determine psilocybin and psilocin potency in mushroomsSince the 1970s, the federal government has listed the active ingredients in mushrooms-;psilocybin and psilocin-;as illegal and having no accepted medical use.
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers find branched chain amino acid supplementation may aid in concussion recoveryIn the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists from the Minds Matter Concussion Frontier Program at Children's Hospital of Philadelphia (CHOP) have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of...
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers find unanticipated complexity in aging brain's memory declineResearchers from The University of Texas at Dallas Center for Vital Longevity (CVL) have discovered that brain correlates of age-related memory decline are more complicated than previously believed, a finding that could affect efforts to preserve cognitive health in older people.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers pinpoint issue that could be hampering common chemotherapy drugResearchers at the University of Toronto's Donnelly Centre for Cellular and Biomolecular Research have found two enzymes that work against the chemotherapy drug gemcitabine, preventing it from effectively treating pancreatic cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »